301 related articles for article (PubMed ID: 21705616)
1. IFN-α confers resistance of systemic lupus erythematosus nephritis to therapy in NZB/W F1 mice.
Liu Z; Bethunaickan R; Huang W; Ramanujam M; Madaio MP; Davidson A
J Immunol; 2011 Aug; 187(3):1506-13. PubMed ID: 21705616
[TBL] [Abstract][Full Text] [Related]
2. Interferon-α accelerates murine systemic lupus erythematosus in a T cell-dependent manner.
Liu Z; Bethunaickan R; Huang W; Lodhi U; Solano I; Madaio MP; Davidson A
Arthritis Rheum; 2011 Jan; 63(1):219-29. PubMed ID: 20954185
[TBL] [Abstract][Full Text] [Related]
3. Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition.
Schiffer L; Sinha J; Wang X; Huang W; von Gersdorff G; Schiffer M; Madaio MP; Davidson A
J Immunol; 2003 Jul; 171(1):489-97. PubMed ID: 12817034
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of action of transmembrane activator and calcium modulator ligand interactor-Ig in murine systemic lupus erythematosus.
Ramanujam M; Wang X; Huang W; Schiffer L; Grimaldi C; Akkerman A; Diamond B; Madaio MP; Davidson A
J Immunol; 2004 Sep; 173(5):3524-34. PubMed ID: 15322217
[TBL] [Abstract][Full Text] [Related]
5. Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice.
Haas KM; Watanabe R; Matsushita T; Nakashima H; Ishiura N; Okochi H; Fujimoto M; Tedder TF
J Immunol; 2010 May; 184(9):4789-800. PubMed ID: 20368280
[TBL] [Abstract][Full Text] [Related]
6. Abrogation of pathogenic IgG autoantibody production in CD40L gene-deleted lupus-prone New Zealand Black mice.
Pau E; Chang NH; Loh C; Lajoie G; Wither JE
Clin Immunol; 2011 May; 139(2):215-27. PubMed ID: 21414847
[TBL] [Abstract][Full Text] [Related]
7. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
Enghard P; Langnickel D; Riemekasten G
Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
[TBL] [Abstract][Full Text] [Related]
8. Roles of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice.
Nakajima A; Hirose S; Yagita H; Okumura K
J Immunol; 1997 Feb; 158(3):1466-72. PubMed ID: 9013993
[TBL] [Abstract][Full Text] [Related]
9. High frequency of autoantibody-secreting cells and long-lived plasma cells within inflamed kidneys of NZB/W F1 lupus mice.
Starke C; Frey S; Wellmann U; Urbonaviciute V; Herrmann M; Amann K; Schett G; Winkler T; Voll RE
Eur J Immunol; 2011 Jul; 41(7):2107-12. PubMed ID: 21484784
[TBL] [Abstract][Full Text] [Related]
10. Dual B cell immunotherapy is superior to individual anti-CD20 depletion or BAFF blockade in murine models of spontaneous or accelerated lupus.
Lin W; Seshasayee D; Lee WP; Caplazi P; McVay S; Suto E; Nguyen A; Lin Z; Sun Y; DeForge L; Balazs M; Martin F; Zarrin AA
Arthritis Rheumatol; 2015 Jan; 67(1):215-24. PubMed ID: 25303150
[TBL] [Abstract][Full Text] [Related]
11. B Cell and BAFF dependence of IFN-α-exaggerated disease in systemic lupus erythematosus-prone NZM 2328 mice.
Jacob N; Guo S; Mathian A; Koss MN; Gindea S; Putterman C; Jacob CO; Stohl W
J Immunol; 2011 Apr; 186(8):4984-93. PubMed ID: 21383240
[TBL] [Abstract][Full Text] [Related]
12. Soluble human CD83 ameliorates lupus in NZB/W F1 mice.
Starke C; Steinkasserer A; Voll RE; Zinser E
Immunobiology; 2013 Nov; 218(11):1411-5. PubMed ID: 23886695
[TBL] [Abstract][Full Text] [Related]
13. An Ig mu-heavy chain transgene inhibits systemic lupus erythematosus immunopathology in autoimmune (NZB x NZW)F1 mice.
Wellmann U; Letz M; Schneider A; Amann K; Winkler TH
Int Immunol; 2001 Dec; 13(12):1461-9. PubMed ID: 11717187
[TBL] [Abstract][Full Text] [Related]
14. HSPB5 suppresses renal inflammation and protects lupus-prone NZB/W F1 mice from severe renal damage.
Knapp J; Braunstein M; Berg SIT; Shirriff C
Arthritis Res Ther; 2022 Dec; 24(1):267. PubMed ID: 36510250
[TBL] [Abstract][Full Text] [Related]
15. Docosahexaenoic acid-enriched fish oil attenuates kidney disease and prolongs median and maximal life span of autoimmune lupus-prone mice.
Halade GV; Rahman MM; Bhattacharya A; Barnes JL; Chandrasekar B; Fernandes G
J Immunol; 2010 May; 184(9):5280-6. PubMed ID: 20368275
[TBL] [Abstract][Full Text] [Related]
16. Long-term administration of IgG2a anti-NK1.1 monoclonal antibody ameliorates lupus-like disease in NZB/W mice in spite of an early worsening induced by an IgG2a-dependent BAFF/BLyS production.
Postól E; Meyer A; Cardillo F; de Alencar R; Pessina D; Nihei J; Mariano M; Mengel J
Immunology; 2008 Oct; 125(2):184-96. PubMed ID: 18397273
[TBL] [Abstract][Full Text] [Related]
17. Role of microRNA-15a in autoantibody production in interferon-augmented murine model of lupus.
Yuan Y; Kasar S; Underbayev C; Vollenweider D; Salerno E; Kotenko SV; Raveche E
Mol Immunol; 2012 Sep; 52(2):61-70. PubMed ID: 22578383
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies from long-lived 'memory' plasma cells of NZB/W mice drive immune complex nephritis.
Cheng Q; Mumtaz IM; Khodadadi L; Radbruch A; Hoyer BF; Hiepe F
Ann Rheum Dis; 2013 Dec; 72(12):2011-7. PubMed ID: 24114925
[TBL] [Abstract][Full Text] [Related]
19. IFN-alpha induces early lethal lupus in preautoimmune (New Zealand Black x New Zealand White) F1 but not in BALB/c mice.
Mathian A; Weinberg A; Gallegos M; Banchereau J; Koutouzov S
J Immunol; 2005 Mar; 174(5):2499-506. PubMed ID: 15728455
[TBL] [Abstract][Full Text] [Related]
20. Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule.
Nakajima A; Azuma M; Kodera S; Nuriya S; Terashi A; Abe M; Hirose S; Shirai T; Yagita H; Okumura K
Eur J Immunol; 1995 Nov; 25(11):3060-9. PubMed ID: 7489744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
